S Sumitani
Overview
Explore the profile of S Sumitani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
234
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Numata S, Ueno S, Iga J, Yamauchi K, Hongwei S, Kinouchi S, et al.
J Neural Transm (Vienna)
. 2006 Aug;
114(2):255-9.
PMID: 16897602
Catechol-O-methyltransferase (COMT) gene is one of the candidate genes for schizophrenia because it codes an enzyme that participates in the metabolic inactivation of dopamine and noradrenaline and a limiting factor...
2.
Goya K, Kitamura T, Inaba M, Otsuki M, Yamamoto H, Kurebayashi S, et al.
Metabolism
. 2003 Oct;
52(10):1302-6.
PMID: 14564682
Atherosclerotic vascular diseases are frequently associated with diabetes mellitus. There has been increasing evidence showing that the atherosclerotic diseases in diabetic patients are distinct from diabetic microvascular complications as to...
3.
Hirose T, Miyashita Y, Takagi M, Sumitani S, Kouhara H, Kasayama S
Diabetes Res Clin Pract
. 2001 Sep;
54(1):9-15.
PMID: 11532325
In this study, we characterized type 2 diabetic patients responding well to the alpha-glucosidase inhibitor voglibose administration as an adjunct to sulfonylurea treatment. Thirty-three type 2 diabetic patients were enrolled...
4.
Otsuki M, Saito H, Xu X, Sumitani S, Kouhara H, Kurabayashi M, et al.
Atherosclerosis
. 2001 Aug;
158(1):121-8.
PMID: 11500182
Cilostazol is a specific inhibitor of cAMP phosphodiesterase, which is used for treatment of ischemic symptoms of peripheral vascular disease. Although cilostazol has antiplatelet and vasodilator properties, its effect on...
5.
Xu X, Otsuki M, Saito H, Sumitani S, Yamamoto H, Asanuma N, et al.
Endocrinology
. 2001 Jul;
142(8):3332-9.
PMID: 11459775
The antiinflammatory action of glucocorticoids is mediated partly by the inhibition of the expression of several cytokines and adhesion molecules. Some activators for nuclear receptors other than the GR have...
6.
Kurebayashi S, Sumitani S, Kasayama S, Jetten A, Hirose T
Endocr J
. 2001 Jul;
48(2):249-53.
PMID: 11456275
Tumor necrosis factor-alpha (TNF-alpha) has been reported to inhibit adipocyte differentiation in which multiple transcription factors including CCAAT enhancer binding proteins (C/EBPs) and peroxisome proliferator-activated receptor (PPAR) gamma play an...
7.
Otsuki M, Kasayama S, Yamamoto H, Saito H, Sumitani S, Kouhara H, et al.
Clin Endocrinol (Oxf)
. 2001 Jun;
54(6):791-6.
PMID: 11422114
Objective: Acromegalic patients have increased mortality from vascular diseases. Although atherosclerotic risk factors such as hypertension, diabetes mellitus and dyslipoproteinaemia are highly associated with acromegaly, the prevalence of premature atherosclerosis...
8.
Otsuki M, Saito H, Xu X, Sumitani S, Kouhara H, Kishimoto T, et al.
Arterioscler Thromb Vasc Biol
. 2001 Feb;
21(2):243-8.
PMID: 11156860
-It has been shown that ovarian steroid hormones can reduce the incidence of cardiovascular disease in postmenopausal women. As hormone replacement therapy for postmenopausal women, progestins are added to estrogens...
9.
Kasayama S, Otsuki M, Takagi M, Saito H, Sumitani S, Kouhara H, et al.
Clin Endocrinol (Oxf)
. 2000 May;
52(5):549-55.
PMID: 10792333
Objective: Abnormal glucose tolerance is often demonstrated in acromegalic patients. Although insulin resistance is a common feature of acromegaly, it remains unclear whether the extent of insulin resistance per se...
10.
Sumitani S, Ishikawa Y, Minami R
J Child Neurol
. 1999 Apr;
14(3):168-72.
PMID: 10190268
Xeroderma pigmentosum is an autosomal recessive disease characterized by extreme sensitivity of the skin to ultraviolet light, which results in a high incidence of early skin cancer. We report here...